SCHEMBL31522017

SCHEMBL31522017

COC(=O)c1cccc(Br)c1Oc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.52
▸ TSHR P16473 4/20 0.46
▸ LMNA P02545 1/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ HSD17B10 Q99714 3/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ CFTR P13569 1/20 0.45
▸ SLC6A3 Q01959 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ CA1 P00915 1/20 0.44
▸ CA2 P00918 1/20 0.44
▸ CA5A P35218 1/20 0.44
▸ CA9 Q16790 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ POLB P06746 1/20 0.44
▸ ATM Q13315 1/20 0.44
▸ MAPK10 P53779 1/20 0.43
▸ GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31522075 0.83 PRNP (0.47) NPC1RAB9AHSD17B10ALDH1A1MAPT
SCHEMBL4955520 0.83 TDP1 (0.54) TDP1TSHRLMNAHSD17B10ALDH1A1
SCHEMBL184184 0.82 LMNA (0.48) TSHRLMNANPC1RAB9AHSD17B10
SCHEMBL28829625 0.81 TDP1 (0.52) TDP1TSHRLMNANPC1RAB9A
SCHEMBL28328625 0.81 TDP1 (0.52) TDP1TSHRLMNARAB9AHSD17B10
SCHEMBL27872615 0.81 CTNNB1 (0.57) TSHRHSD17B10ALDH1A1MAPTKDM4E
Dimethyl Phthalate SCHEMBL28487305 0.79 TDP1 (0.65) TDP1TSHRLMNARAB9AHSD17B10
Bicarbonate SCHEMBL20918171 0.78 TSHR (0.57) TSHRLMNAHSD17B10ALDH1A1CFTR
SCHEMBL23659 0.77 TSHR (0.61) TSHRLMNANPC1RAB9AHSD17B10
SCHEMBL29433258 0.77 TSHR (0.61) TSHRLMNANPC1RAB9AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250084056-A1 SUBSTITUTED OXOISOINDOLINYL PIPERIDINE-2,6-DIONE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2025-03-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250084056-A1 SUBSTITUTED OXOISOINDOLINYL PIPERIDINE-2,6-DIONE COMPOUNDS CCNA1, CCNI, CCNE1 TDP1 965/4885TSHR 2650/4885LMNA 470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback